Jae-Seung Yoon
Director/Board Member bij INSUNG INFORMATION CO., LTD
Vermogen: 105 M $ op 31-03-2024
Profiel
Jae-Seung Yoon currently works at INSUNG INFORMATION Co., Ltd., as Non-Executive Director from 1995 and Healience Co., Ltd., as Director.
Mr. Yoon also formerly worked at Daewoong Co., Ltd., as Chief Executive Officer from 1995 to 2010, Daewoong Pharmaceutical Co., Ltd., as Chairman & Co-Chief Executive Officer, SK Telecom Co., Ltd., as Non-Executive Director, NAVER Corp., as Independent Director from 2008 to 2013, Dongnam Chemical Co., Ltd., as Director, Daewoong Bio, Inc., as Director, Ezmedicom Co. Ltd., as Director, and Bioalpha, Inc., as Director.
Mr. Yoon received his graduate degree from Seoul National University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
DAEWOONG CO., LTD.
11.87% | 13-03-2023 | 6 902 660 ( 11.87% ) | 104 M $ | 31-03-2024 |
| 01-02-2024 | 672 206 ( 1.71% ) | 2 M $ | 31-03-2024 |
Actieve functies van Jae-Seung Yoon
| Bedrijven | Functie | Begin |
|---|---|---|
| INSUNG INFORMATION CO., LTD | Director/Board Member | 01-04-1995 |
Healience Co., Ltd.
 Healience Co., Ltd. Hotels/Resorts/Cruise linesConsumer Services Part of Daewoong Co., Ltd., Healience Co., Ltd. is a South Korean company that provides tourist accommodation. The private company is based in Hongcheon, South Korea and was founded in 2005. | Director/Board Member | 05-07-2011 |
Eerdere bekende functies van Jae-Seung Yoon
| Bedrijven | Functie | Einde |
|---|---|---|
| DAEWOONG PHARMACEUTICAL CO., LTD | Chief Executive Officer | 27-08-2018 |
| NAVER CORPORATION | Director/Board Member | - |
Daewoong Bio, Inc.
 Daewoong Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Daewoong Bio, Inc. provides pharmaceutical raw materials and intermediate products. Its products include acids, anti-hyperlipidaemic agents, tranquilisers, antiulcerants, antifungals, dietary supplements, anti-thrombotics, cephalosporins, anti-hypertensives, hepatic protectors, penicillin, digestives, diphenyl dimethyl bicarboxylate, amoxicillin, and alibendol. The company was founded on April 15, 1983 and is headquartered in Hwaseong, South Korea. | Director/Board Member | - |
| DONGNAM CHEMICAL CO., LTD. | Director/Board Member | - |
| Bioalpha, Inc. | Director/Board Member | - |
Opleiding van Jae-Seung Yoon
| Seoul National University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 5 |
|---|---|
| SK TELECOM CO., LTD. | Communications |
| DAEWOONG CO., LTD. | Health Technology |
| DAEWOONG PHARMACEUTICAL CO., LTD | Health Technology |
| NAVER CORPORATION | Technology Services |
| DONGNAM CHEMICAL CO., LTD. | Consumer Non-Durables |
| Bedrijven in privébezit | 5 |
|---|---|
| INSUNG INFORMATION Co., Ltd. | |
Daewoong Bio, Inc.
Daewoong Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Daewoong Bio, Inc. provides pharmaceutical raw materials and intermediate products. Its products include acids, anti-hyperlipidaemic agents, tranquilisers, antiulcerants, antifungals, dietary supplements, anti-thrombotics, cephalosporins, anti-hypertensives, hepatic protectors, penicillin, digestives, diphenyl dimethyl bicarboxylate, amoxicillin, and alibendol. The company was founded on April 15, 1983 and is headquartered in Hwaseong, South Korea. | Commercial Services |
Healience Co., Ltd.
Healience Co., Ltd. Hotels/Resorts/Cruise linesConsumer Services Part of Daewoong Co., Ltd., Healience Co., Ltd. is a South Korean company that provides tourist accommodation. The private company is based in Hongcheon, South Korea and was founded in 2005. | Consumer Services |
| Bioalpha, Inc. | |
Ezmedicom Co. Ltd.
 Ezmedicom Co. Ltd. Medical DistributorsDistribution Services Part of Daewoong Co., Ltd., Ezmedicom Co. Ltd. is a medical e-commerce leader that leads the way in medical e-business. The South Korean company promises a win-win for purchasing hospitals, suppliers, and investors as a future-oriented company. The text is in Korean and has been translated to English. | Distribution Services |
